Stocks · Korea 205470 KOSDAQ

Humasis

3,120원 +19.77% Market cap 770억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR0.33x
EPS0 KRW
BPS9,505 KRW
ROE-14.29%
DPS0 KRW

Returns and 52-week range

1W+20.00%
1M-2.95%
3M+35.36%
6M-15.79%
1Y-56.12%
YTD-39.94%
52W high6,855원
52W low1,898원
From 52W high-54.49%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20213,218억1,936억1,512억60.1%
2023138억-524억-554억-378.6%
2024254억-106억-356억-41.5%
2025301억-106억-217억-35.0%
Quarterly
2024 2Q11억-30억12억-276.5%
2024 3Q105억-11억-47억-10.5%
2024 4Q119억-29억-336억-24.7%
2025 1Q62억-27억-30억-44.3%
2025 3Q87억-25억-3억-28.4%
2026 1Q89억-16억33억-18.2%

Company

CEO박우람
Founded2014-08-29
Fiscal year end12
Address: 경기도 군포시 군포첨단산업2로 37 (부곡동) 휴마시스㈜

Peers in the same sector

CompanyMarket capP/EP/B1M
신일제약783억10.030.50+9.63%
씨티씨바이오730억22.210.99-1.31%
폴라리스AI파마789억12.800.58+11.44%
일동홀딩스724억6.480.43-0.48%
삼익제약815억—1.08+42.86%
HLB제넥스710억2.811.55+11.69%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.